Similarly, the enhanced YB-1 release during melanoma progression cannot be explained by a generally elevated protein secretion from the tumour cells as assessed by Coomassie staining of the size-separated supernatant samples (Figure S2c). The gene discussed is YBX1; the disease is melanoma.